SGLT-2 inhibitors for people with type 2 diabetes

Lancet. 2019 Aug 17;394(10198):559-560. doi: 10.1016/S0140-6736(19)30720-2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Dipeptidyl-Peptidase IV Inhibitors*
  • Humans
  • Hypoglycemic Agents
  • Secondary Prevention
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors